Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.
O'Konek JJ, Illarionov P, Khursigara DS, Ambrosino E, Izhak L, Castillo BF 2nd, Raju R, Khalili M, Kim HY, Howell AR, Besra GS, Porcelli SA, Berzofsky JA, Terabe M.
O'Konek JJ, et al. Among authors: ambrosino e.
J Clin Invest. 2011 Feb;121(2):683-94. doi: 10.1172/JCI42314. Epub 2011 Jan 18.
J Clin Invest. 2011.
PMID: 21245578
Free PMC article.